Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$65.07 - $98.24 $604,240 - $912,256
-9,286 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$59.04 - $77.95 $26,745 - $35,311
-453 Reduced 4.65%
9,286 $604,000
Q1 2020

May 15, 2020

SELL
$27.51 - $57.29 $1.99 Million - $4.15 Million
-72,462 Reduced 88.15%
9,739 $331,000
Q4 2019

Feb 18, 2020

BUY
$40.86 - $57.65 $326,880 - $461,200
8,000 Added 10.78%
82,201 $4.48 Million
Q3 2019

Nov 14, 2019

BUY
$37.38 - $49.47 $2.77 Million - $3.67 Million
74,201 New
74,201 $3.1 Million

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Capital International Sarl Portfolio

Follow Capital International Sarl and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Sarl, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Sarl with notifications on news.